Preterm Birth and 17OHP - Why the FDA Should Not Withdraw Approval.

Preterm Birth and 17OHP FDA withdrawal of the approval for 17OHP, as imperfect as the drug may be, will leave a very vulnerable demographic group of U.S. women at high risk for recurrent preterm bi...